The extracellular matrix modulates the hallmarks of cancer
Reads0
Chats0
TLDR
It is suggested that the success of cancer prevention and therapy programs requires an intimate understanding of the reciprocal feedback between the evolving extracellular matrix, the tumor cells and its cancer‐associated cellular stroma.Abstract:
The extracellular matrix regulates tissue development and homeostasis, and its dysregulation contributes to neoplastic progression. The extracellular matrix serves not only as the scaffold upon which tissues are organized but provides critical biochemical and biomechanical cues that direct cell growth, survival, migration and differentiation and modulate vascular development and immune function. Thus, while genetic modifications in tumor cells undoubtedly initiate and drive malignancy, cancer progresses within a dynamically evolving extracellular matrix that modulates virtually every behavioral facet of the tumor cells and cancer-associated stromal cells. Hanahan and Weinberg defined the hallmarks of cancer to encompass key biological capabilities that are acquired and essential for the development, growth and dissemination of all human cancers. These capabilities include sustained proliferation, evasion of growth suppression, death resistance, replicative immortality, induced angiogenesis, initiation of invasion, dysregulation of cellular energetics, avoidance of immune destruction and chronic inflammation. Here, we argue that biophysical and biochemical cues from the tumor-associated extracellular matrix influence each of these cancer hallmarks and are therefore critical for malignancy. We suggest that the success of cancer prevention and therapy programs requires an intimate understanding of the reciprocal feedback between the evolving extracellular matrix, the tumor cells and its cancer-associated cellular stroma.read more
Citations
More filters
Journal ArticleDOI
Bacillus anthracis Protective Antigen Shows High Specificity for a UV Induced Mouse Model of Cutaneous Squamous Cell Carcinoma.
Theo Crawford,Nicholas L. Fletcher,Margaret Veitch,Jazmina L. G. Cruz,Nicola Pett,Ian M. Brereton,James W. Wells,Mehdi Mobli,Yasvir A. Tesiram +8 more
TL;DR: The results suggest that PA could be systemically administered for rapid identification of cutaneous SCC, with potential for further therapeutic development.
Journal ArticleDOI
Epigenetic regulation and targeting of ECM for cancer therapy.
TL;DR: This mini-review discusses epigenetic modifications that regulate the expression of fibrous ECM proteins and glycoproteins and the prospects of targeting them for cancer therapy.
Journal ArticleDOI
Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma.
TL;DR: In conclusion, Jiang et al. provide proof of concept that FAK inhibitors combined with chemotherapy will highly profit PDAC patients.
Journal ArticleDOI
Differentiation of myofibroblasts in wounds after topical use of metronidazole: an experimental study.
Lilian Cristine Teixeira Trindade,Jorge Eduardo Fouto Matias,Cláudia Paraguaçu Pupo Sampaio,Rogério Estevam Farias,Maria de Lourdes Pessole Biondo-Simões +4 more
TL;DR: In this paper, a contracao da ferida foi avaliada by planimetria digital and os miofibroblastos and protomiofibrroblasto for instance were identificados usando a-SMA.
Posted ContentDOI
mTOR repression in response to amino acid starvation promotes ECM degradation through MT1-MMP endocytosis arrest
Cecilia Colombero,David Remy,Sandra Antoine,Anne-Sophie Macé,Pedro Monteiro,Nadia Elkhatib,Margot Fournier,Ahmed Dahmani,Elodie Montaudon,Guillaume Montagnac,Elisabetta Marangoni,Philippe Chavrier +11 more
TL;DR: In this article, the authors show that pericellular matrix degradation by starved cells is controlled by mTOR repression upon nutrient depletion or pharmacological inhibition by rapamycin, leading to the repurposing of abundant plasma membrane clathrin-coated pits into robust ECM-degradative assemblies.
References
More filters
Journal ArticleDOI
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI
The hallmarks of cancer.
TL;DR: This work has been supported by the Department of the Army and the National Institutes of Health, and the author acknowledges the support and encouragement of the National Cancer Institute.
Journal ArticleDOI
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
TL;DR: It is proposed that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass needed to produce a new cell.
Journal ArticleDOI
Role of YAP/TAZ in mechanotransduction
Sirio Dupont,Leonardo Morsut,Mariaceleste Aragona,Elena Enzo,Stefano Giulitti,Michelangelo Cordenonsi,Francesca Zanconato,Jimmy Le Digabel,Mattia Forcato,Silvio Bicciato,Nicola Elvassore,Stefano Piccolo +11 more
TL;DR: YAP/TAZ are identified as sensors and mediators of mechanical cues instructed by the cellular microenvironment and are functionally required for differentiation of mesenchymal stem cells induced by ECM stiffness and for survival of endothelial cells regulated by cell geometry.
Journal ArticleDOI
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental,Hongmei Yu,Laura Kass,Johnathon N. Lakins,Mikala Egeblad,Janine T. Erler,Sheri F. T. Fong,Katalin Csiszar,Amato J. Giaccia,Wolfgang Weninger,Mitsuo Yamauchi,David L. Gasser,Valerie M. Weaver +12 more
TL;DR: Reduction of lysyl oxidase-mediated collagen crosslinking prevented MMTV-Neu-induced fibrosis, decreased focal adhesions and PI3K activity, impeded malignancy, and lowered tumor incidence, and data show how collagenCrosslinking can modulate tissue fibrosis and stiffness to force focal adhesion, growth factor signaling and breast malignancies.